Dana Rathkopf

10PUBLICATIONS
169CO-AUTHORS
Radiation therapyCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targetsPacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 19, 2026
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Feb 06, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.

Marina N Sharifi, Jamie M Sperger, Amy K Taylor

|Sep 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.

Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann

|Jul 01, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.

Andrew T Lenis, Vignesh Ravichandran, Samantha Brown

|Jan 08, 2024
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.

Naiyu Chen, Colleen B McGrath, Caroline I Ericsson

Pageof 2

Frequent Collaborators

4 joint publications

Elisabeth I Heath

4 joint publications

Karen A Autio

3 joint publications

Rana R McKay

3 joint publications

Howard Scher